Lung Cancer Congress: Progress Toward Cure
June 18-19, 2021
Overview
The 3rd Middle East Lung Cancer Congress is a platform for discussing recent advances in understanding the pathophysiology of lung cancer. It aims to enhance multidisciplinary collaboration between various specialties involved in the care of lung cancer patients.
Target Audience
This congress is designed for medical oncologists, radiation oncologists, surgeons, radiologists, radiation oncologists, pathologists, pulmonologists, academic scientists, residents, fellows, nurses, pharmacists, chemo therapists, clinical professionals, young researchers, researchers, postgraduates, trainees, medical students and industry professionals.
Endorsements
This activity is endorsed by the Lebanese Society of Medical Oncology (LSMO), the Lebanese Pulmonary Society, the Lebanese Society of Pathology, the Lebanese Society of Family Medicine, and the Lebanese Society of Radiology.
Lebanese Order of Physicians (LOP) Accreditation
This activity complies with the Lebanese Order of Physicians’ Continuing Medical Education guidelines.
Order of Pharmacists in Lebanon (OPL) Accreditation
This activity complies with the Order of Pharmacists in Lebanon’s Continuing Pharmacy Education guidelines.
American Nursing Credentialing Center (ANCC) Accreditation
This activity complies with the American Nursing Credentialing Center’s Continuing Nursing Education guidelines.
Pre-Registration is Mandatory – Deadline for registration is June 17, 2021
This congress will be delivered online, for more details on the program please visit: